A detailed history of Svb Wealth LLC transactions in Csl LTD stock. As of the latest transaction made, Svb Wealth LLC holds 3,492 shares of CSLLY stock, worth $364,250. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,492
Previous 4,436 21.28%
Holding current value
$364,250
Previous $418,000 17.94%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$86.82 - $98.5 $81,958 - $92,984
-944 Reduced 21.28%
3,492 $343,000
Q1 2024

May 15, 2024

BUY
$89.91 - $99.41 $46,483 - $51,394
517 Added 13.19%
4,436 $418,000
Q4 2023

Jan 30, 2024

BUY
$73.1 - $97.93 $97,880 - $131,128
1,339 Added 51.9%
3,919 $380,000
Q3 2023

Oct 23, 2023

SELL
$80.15 - $92.62 $104,034 - $120,220
-1,298 Reduced 33.47%
2,580 $208,000
Q2 2023

Jul 24, 2023

BUY
$91.49 - $104.64 $18,572 - $21,241
203 Added 5.52%
3,878 $357,000
Q1 2023

May 12, 2023

SELL
$92.92 - $109.35 $24,159 - $28,431
-260 Reduced 6.61%
3,675 $355,000
Q4 2022

Feb 10, 2023

SELL
$84.9 - $102.89 $18,762 - $22,738
-221 Reduced 5.32%
3,935 $383,000
Q3 2022

Nov 09, 2022

BUY
$90.51 - $207.38 $376,159 - $861,871
4,156 New
4,156 $379,000
Q2 2022

Aug 16, 2022

SELL
$87.94 - $101.67 $193,380 - $223,572
-2,199 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$85.56 - $107.12 $188,146 - $235,556
2,199 New
2,199 $219,000
Q4 2021

Feb 15, 2022

SELL
$97.41 - $116.74 $1.31 Million - $1.57 Million
-13,473 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$101.72 - $114.56 $157,157 - $176,995
1,545 Added 12.95%
13,473 $1.41 Million
Q2 2021

Aug 13, 2021

BUY
$100.62 - $116.66 $892,801 - $1.04 Million
8,873 Added 290.44%
11,928 $1.27 Million
Q1 2021

May 11, 2021

SELL
$95.11 - $111.11 $253,658 - $296,330
-2,667 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$101.34 - $117.74 $270,273 - $314,012
2,667 New
2,667 $291,000

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $101B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.